SP

SkyLake Equity Partners‍‍‍‍‍‌‌​‍​​‍‌‌​‌‍‍‌‍

company active
Co-investor with Crescendo in Medipost
Tracked:Co-investor with Crescendo in Medipost · 2 documented connections
7
Facts
2
Connections
10
Sources
View on Graph → Export CSV ← Entity Directory
Connection Map
Key Connections
Medipost company
owner
Skylake is the co-lead investor and the largest shareholder of Medipost, with a 22.28% stake. It has been instrumental in the company's operational restructuring.
Crescendo Equity Partners company
co-investor
SkyLake Equity Partners and Crescendo Equity Partners jointly acquired Medipost in 2022 and have co-led subsequent funding rounds, including a $140 million investment in January 2026.
Facts (7)
Data Freshness
Fresh Last update: 1d ago · Avg age: 112d
Confidence Tiers: Primary Source — cross-referenced government/corporate filings Pending Review — sourced but not independently verified AI Inference — analytical hypothesis from cross-referencing
Documented Records (7)
Sourced from government databases, press reports, and corporate filings. Not yet independently verified.
Primary Source The firm is led by co-CEOs Dae-Je Chin (founder of SkyLake Investment and fo‍‍‍‍‍‌‌​‍​​‍‌‌​‌‍‍‌‍rmer South Korean Minister of Information and Communication) and Hyun-Ki Min.
Date: 2019-06-15 Added: 20 Apr 2026 ↗ SOURCE: Dae-Je Chin
Partially Corroborated Notable portfolio companies include Yanolja (travel tech), KDA (auto parts), Coating Korea, Nexp‍‍‍‍‍‌‌​‍​​‍‌‌​‌‍‍‌‍lex, Helinox, BusinessOn Communication (SaaS), Shiftee (HR SaaS), and DEEPX (AI semiconductors).
Partially Corroborated The firm manages the 10th blind fund of approximately KRW 627.7 billion, with limited partners inclu‍‍‍‍‍‌‌​‍​​‍‌‌​‌‍‍‌‍ding the National Pension Service, Teachers' Credit Union, and Administrative Credit Union of Korea.
Primary Source SkyLake Equity Partners has made 66 investments and 47 exits according to PitchBook, with a portfolio spanning technology, biotechnology, consumer goods, industrial goods, media, telecommunications, and financial services.
Primary Source Skylake Equity Partners and Crescendo Equity Partners acquired management control of Medipost in 2022, jointly investing 211.8 billion won ($147.1 million). They remain the two largest shareholders with stakes of 22.28% and 20.91% respectively as of early 2026.
Primary Source SkyLake Equity Partners co-led a $140 million funding round for Medipost in January 2026 alongside Crescendo Equity Partners, with participation from Korea's growth equity fund.
Date: 2026-01-09 Added: 20 Apr 2026 ↗ SOURCE: MEDIPOST Raises $140M in Funding
Primary Source Skylake Equity Partners was spun off from SkyLake Investment in 2019 and is based in Seoul, South Korea. It specializes in technology private equity with a focus on buyout and growth investments.
All Connections (2)
Medipost company
owner primary
Skylake is the co-lead investor and the largest shareholder of Medipost, with a 22.28% stake. It has been instrumental in the company's operational restructuring.
co-investor primary
SkyLake Equity Partners and Crescendo Equity Partners jointly acquired Medipost in 2022 and have co-led subsequent funding rounds, including a $140 million investment in January 2026.
Sources (10)
↗ Dae-Je Chin external_handoff Processed
2026-01-12 ↗ MEDIPOST Raises $140M in Funding external_handoff Processed
2026-04-19 UNVERIFIED SEARCH_ERROR: SkyLake Equity Partners not found in opencorporates claim_flag Processed